Shoddy biopsies deny cancer patients a shot at personalized treatment
Elie Dolgin • Jan 22, 2016
A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren’t robust enough to be put through genetic analysis.
Continue reading at
STAT.
The new fiber-optic probe could transform aneurysm and brain clot treatments
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.